Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Proteaphagy contributes to bortezomib resistance in mantle cell lymphoma

ABSTRACT: TUBE and GST enrichment followed by 1D-gel-LC-MS analysis on cell exract from bortezomib (BTZ)-resistant or sensitive mantle cell lymphoma cells.

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo Sapiens (human)

DISEASE(S): Lymphoma

SUBMITTER: Rune Matthiesen

LAB HEAD: Manuel S. Rodriguez [1]/Rune Matthiesen [2]

PROVIDER: PXD011867 | Pride | 2022-02-28

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	PepMod.txt	Txt
	ProMod.txt	Txt
	R4_Z138_GST_1.RAW	Raw
	R4_Z138_GST_1.txt	Txt
	R4_Z138_GST_10.RAW	Raw

Items per page:

1 - 5 of 357

Publications

Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma.

Quinet Grégoire G Xolalpa Wendy W Reyes-Garau Diana D Profitós-Pelejà Núria N Azkargorta Mikel M Ceccato Laurie L Gonzalez-Santamarta Maria M Marsal Maria M Andilla Jordi J Aillet Fabienne F Bosch Francesc F Elortza Felix F Loza-Alvarez Pablo P Sola Brigitte B Coux Olivier O Matthiesen Rune R Roué Gaël G Rodriguez Manuel S MS

Cancers 20220212 4

Protein ubiquitylation coordinates crucial cellular events in physiological and pathological conditions. A comparative analysis of the ubiquitin proteome from bortezomib (BTZ)-sensitive and BTZ-resistant mantle cell lymphoma (MCL) revealed an enrichment of the autophagy-lysosome system (ALS) in BTZ-resistant cells. Pharmacological inhibition of autophagy at the level of lysosome-fusion revealed a constitutive activation of proteaphagy and accumulation of proteasome subunits within autophagosomes ...[more]

PMID: 35205670

Similar Datasets

Human, bronchoalveolar lavage, extracellular vesicles

Project description:The aim of the project was to explore large extracellular vesicles capacity to seperate non lung cancer from lung cancer cases. A case control study of patients suspected for lung cancer (12 non lung cancer and 12 lung cancers). The raw files are labeled according to clinical status. Small and large extracellular vesicles were isolated by differential centrifugation. The proteome of full BAL, vesicle depleted BAL, small and large extracellular vesicles were characterized by LC-MS. Small extracellular vesicles were further analyzed by nanoparticle tracking analysis, Transmission electron microscopy and western blots.

2020-12-15 | PXD021988 | Pride

Unbiased undepleted malignant pleural effusion proteomics study

Project description:Pleural effusion (PE) occurs as a consequence of various pathologies. Malignant effusion due to lung cancer is one of the most frequent causes. Methods for accurate differentiation of malignant from benign PE cases are an unmet clinical need. Proteomics profiling of PE has shown promising results. However, mass spectrometry (MS) analysis typically involves the tedious elimination of abundant proteins before analysis, and clinical annotation of proteomics profiled cohorts is limited. In this study, PE from 97 patients was investigated by applying label-free state-of-the-art liquid chromatography-mass spectrometry (LC-MS) to find potential novel biomarkers that correlate with immunohistochemistry assessment of tumor biopsy or survival data. The data set consists of 214 LC-MS runs.

2022-10-14 | PXD035884 | Pride

Extracellular vesicles as prognostic biomarkers for Multiple Myeloma - a clinical population-based study

Project description:Multiple myeloma (MM) is an incurable hematological malignancy of mature B lymphocytes. In this study patients with MGUS, SMM and MM followed in two hematology departments were enrolled. Extracellular vesicles were isolated from bone marrow (BM) and peripheral blood (PB) followed by mass spectrometry based bottom up proteomics.

2022-05-31 | PXD024121 | Pride

Bronchoalveolar Lavage proteomics

Project description:Mass spectrometry based proteome analysis on an observational prospective cohort consisting of 90 suspected lung cancer cases (suspicious=7, no lung cancer suspicion=47 and lung cancer=36 as diagnosed in 2014) which were followed during two years (suspicious=2, no lung cancer suspicion= 39 and Lung cancer=49).

2017-02-13 | PXD004700 | Pride

E. coli EcAmb278 treated with tetracycline

Project description:Drug profiling exeriment to elucidate protein regulation upon treatment of a multi-drug resistant E.coli strain with tetracycline.

2017-01-06 | PXD003641 | Pride

ChIP-sequencing analysis of Myc binding sites 4 hours after Myc activation in liver and heart tissue, from wild type and R26CAG-c-MycERT2 mice

Project description:Aim: To determine Myc binding sites in mouse heart and liver, 4 hours post MycER activation. c-Myc ChIP sequencing performed on chromatin isolated from hearts and livers harvested from wild-type (R26+/+) and R26CAG-c-MycERT2/+ mice 4 hours post administration of (Z)-4-hydroxytamoxifen.

2020-02-24 | E-MTAB-7592 | biostudies-arrayexpress

ChIP-sequencing analysis of RNA Pol II binding sites 4 hours after Myc activation in liver and heart tissue, from wild type and R26CAG-c-MycERT2 mice

Project description:Aim: To determine RNA Pol II binding sites in mouse heart and liver, 4 hours post MycER activation. Pol II ChIP sequencing performed on chromatin isolated from hearts and livers harvested from wild-type (R26+/+) and R26CAG-c-MycERT2/+ mice 4 hours post administration of (Z)-4-hydroxytamoxifen.

2020-03-06 | E-MTAB-7593 | biostudies-arrayexpress

Human Diffuse large B cell lymphoma cell lines

Project description:We have analyzed by label free mass spectrometry the whole cells and secreted extracellular vesicles (EVs) proteomes of two different molecular subtypes of DLBCL, germinal center B cell (GCB subtype) and activated B cell (ABC subtype). Cell line: OCI-Ly3 (ABC) O3_2.raw O3_1.raw O2_2.raw O2_1.raw O1_2.raw O1_1.raw Cell line: HT (GCB) H4_2.raw H4_1.raw H3_2.raw H3_1.raw H2_2.raw H2_1.raw H1_2.raw H1_1.raw EVs OCI-Ly3 eO2_2.raw eO2_1.raw eO2.raw eO1_2.raw eO1_1.raw eO1.raw EVs HT eH2_2.raw eH2_1.raw eH2.raw eH1_2.raw eH1_1.raw eH1.raw EVs cell line RIVA: D3_2.raw D3_1.raw D2_2.raw D2_1.raw D1_2.raw D1_1.raw EVs cell line DB: C3_2.raw C3_1.raw C2_2.raw C2_1.raw C1_2.raw C1_1.raw Cell line: RIVA (ABC) B3_2.raw B3_1.raw B2_2.raw B2_1.raw B1_2.raw B1_1.raw Cell line: DB (GCB) A3_2.raw A3_1.raw A2_2.raw A2_1.raw A1_2.raw A1_1.raw

2021-11-04 | PXD028267 | Pride

Comparison of SPEED, S-Trap, and In-Solution based sample preparation methods for tandem mass spectrometry

Project description:Bottom-up proteomic analyses rely on efficient protein extraction from tissue and proteolysis into peptides for mass spectrometry. Commonly used detergent-based strategies aid cell lysis and protein solubilization but are poorly compatible with downstream protein digestion and liquid chromatography-coupled mass spectrometry. Consequently, additional sample purification and buffer exchange steps are required, which are time-consuming and introduce additional technical variability. This study provides the first direct quantitative comparison of two well-established detergent-based methods for protein extraction and solubilization (In-solution and suspension trapping, S-Trap) with the recently developed Sample Preparation by Easy Extraction and Digestion (SPEED) method, which uses a strong acid for denaturation. Identification rates and quantitative performance of each method were compared with data-dependent acquisition (DDA) and label-free SWATH-MS (sequential window acquisition of all theoretical mass spectra) in both sheep kidney cortical tissue and plasma. In kidney tissue, SPEED outperformed In-solution and S-Trap by quantifying the highest number of unique proteins (SPEED 1,250; S-Trap 1,202; In-solution 1,197) and displayed the most efficient proteolysis (SPEED 93.8% of peptides fully tryptic in DDA; S-Trap 88.5%; In-solution 87.3%). In plasma, S-Trap produced the most unique protein quantifications (S-Trap 151; In-solution 148; SPEED 138), indicating it may be the optimal method for this biofluid. Protein quantifications were reproducible across biological replicates in both tissue (R2 from 0.85 to 0.90), and in plasma (SPEED R2=0.84; In-solution R2=0.76, S-Trap R2=0.65). Our data suggest SPEED as the optimal method for proteomic preparation in kidney tissue and S-Trap or SPEED as the optimal method for plasma, depending on whether a higher number of protein quantifications or greater reproducibility is desired.

2023-03-30 | PXD030797 | Pride

Genome-Wide Transcriptional Responses of Nitrosomonas europaea to cadmium

Project description:Heavy metals have been postulated as significant nitrification inhibitor in wastewater treatment plant. The effect of heavy metals such as Cd2+, Cu2+ and Hg2+ to nitrifying bacterium, Nitrosomonas europaea, was studied in pseudo-steady state batch reactor. Under incubation of Nitrosomonas europaea with 1 ?M CdCl2 for 1 hour, transcripts for 66 of 2460 genes were found at high level, yet transcripts of 50 genes were found at low level. Mercury resistance genes (merACDPT) showed 277-fold up regulation. Keywords: cadmium, stress response, global transcription, mercury resistance genes, merA, The 1 uM CdCl2 caused more than 50 % inhibition in physiological response for 1 hour incubation. Transcriptional levels of the cells inhibited by cadmium were compared with the cells under control condition.

2010-05-25 | E-GEOD-9221 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data